comparemela.com

Latest Breaking News On - Josh riemer - Page 1 : comparemela.com

Ventus Therapeutics raises funding to expedite drug discovery platform

ABL Bio and Sanofi partner to develop antibody for Parkinson s disease

ABL Bio and Sanofi entered a partnership and global licence agreement to develop a bispecific antibody, ABL301, for Parkinson’s disease.

People With Machiavellian Personality Support Mind Upload Technology, Experts Say

People With Machiavellian Personality Support Mind Upload Technology, Experts Say
techtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from techtimes.com Daily Mail and Mail on Sunday newspapers.

Lab is exploring brain links to Parkinson s

The National Institute on Aging considers Parkinson’s Disease (PD) is a brain disorder. Other descriptions characterize it as a progressive, neurodegenerative disorder. Scientists know there is a loss of brain cells that produce dopamine, which regulate one’s voluntary movements. But there’s a disturbing limit to what we truly understand about this disorder. According to the NIA, “scientists still do not know what causes cells that produce dopamine to die.” One investigator with a research laboratory in the Van Andel Institute’s Department of Neurodegenerative Science wants to figure that out. Image credits: Josh Riemer. The lab, with its focus on PD, wants to know more about how cells and cell-to-cell communication in the brain are affected by Parkinson’s. The Chu Lab is on a mission to “identify mechanisms that contribute to progressive degeneration of midbrain dopaminergic neurons, and abnormal circuit activity that underlies the devastating motor symptoms of

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.